Leucine-rich repeat (LRR)-containing 3B (LRRC3B) inhibits proliferation and invasion by targeting β-catenin, cyclin D1, and c-Myc in bladder cancer cells; nevertheless, its expression has been observed to be substantially downregulated in BCa (Zhao et al. 2017). This evidence concerns the gene MYC and urinary bladder cancer.